AstraZeneca/Oxford University Covid-19 vaccine MHRA approval

Wockhardt UK, based in Wrexham, North Wales, is delighted with the news that the MHRA has granted temporary authorisation for use of the AstraZeneca/ Oxford University COVID-19 vaccine. Back in August, Wockhardt UK announced that it had entered into an agreement with the UK Government to fill finish COVID-19 vaccines, having reserved manufacturing capacity. The first vaccine it will supply will be the AstraZeneca/ Oxford University vaccine.

Ravi Limaye, MD of Wockhardt UK comments: “We are incredibly proud to be fill finishing the approved AstraZeneca COVID-19 vaccine and play our part in the fight against this global pandemic, not to mention the positive impact it will have on the Wrexham business community.”